A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
NRG Oncology
UMC Utrecht
Neonc Technologies, Inc.
Gustave Roussy, Cancer Campus, Grand Paris
Adela, Inc
Mayo Clinic
University of Southern California
Dana-Farber Cancer Institute
Jonsson Comprehensive Cancer Center
Apollomics Inc.
Columbia University
Algemeen Ziekenhuis Maria Middelares
University of Sydney
Peking Union Medical College Hospital
N.N. Petrov National Medical Research Center of Oncology
Shanghai Yunying Medical Technology